Davis J. E.

Director, CEO and President, EVP-Gen. Diagnostics/CEO Elect, EVP, General Diagnostics · SEC CIK 1599837
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$42.91M
38 trades
Net flow
−$42.91M
Net selling
Total filings
92
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 17, 2020 ΔOwn −1.3%

Davis J. E. sold $45.1K of DGX, trimming their stake 1%.

−$45.1K
500 sh @ $90
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Mar 12, 2020 ΔOwn −8.5%
−$409.4K
3,846 sh @ $106
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Feb 28, 2020 ΔOwn −2.8%

Davis J. E. sold $119.9K of DGX, trimming their stake 3%.

−$119.9K
1,100 sh @ $109
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Feb 28, 2020 ΔOwn −1.2%

Davis J. E. sold $56.7K of DGX, trimming their stake 1%.

−$56.7K
510 sh @ $111
Advertisement
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Feb 28, 2020 ΔOwn −2.9%
−$134K
1,187 sh @ $113
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Feb 26, 2020 ΔOwn −1.4%

Davis J. E. sold $67.4K of DGX, trimming their stake 1%.

−$67.4K
598 sh @ $113
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Feb 26, 2020 ΔOwn −1.3%
−$62.6K
552 sh @ $113
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Feb 26, 2020 ΔOwn −1.5%
−$72.1K
643 sh @ $112
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −32%

Davis J. E. sold $6.14M of DGX, trimming their stake 32%.

−$6.14M
58,258 sh @ $105
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −6.1%

Davis J. E. sold $790.6K of DGX, trimming their stake 6%.

−$790.6K
7,423 sh @ $107
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −60%

Davis J. E. sold $7.28M of DGX, trimming their stake 60%.

−$7.28M
69,003 sh @ $105
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −20%

Davis J. E. sold $942.9K of DGX, trimming their stake 20%.

−$942.9K
8,853 sh @ $107
DGX
Option exercise Davis J. E. · EVP, General Diagnostics · Option exercise · filed Apr 26, 2019 ΔOwn +130%
+$2.89M
47,574 sh @ $61
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Apr 26, 2019 ΔOwn −57%

Davis J. E. sold $4.52M of DGX, trimming their stake 57%.

−$4.52M
47,574 sh @ $95
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Apr 10, 2019 ΔOwn −13%

Davis J. E. sold $531.9K of DGX, trimming their stake 13%.

−$531.9K
5,900 sh @ $90
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Apr 10, 2019 ΔOwn −5.4%

Davis J. E. sold $190.5K of DGX, trimming their stake 5%.

−$190.5K
2,100 sh @ $91
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Mar 5, 2019 ΔOwn −12%
−$507.2K
5,839 sh @ $87
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Feb 28, 2019 ΔOwn −3.4%
−$125.8K
1,432 sh @ $88
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Feb 27, 2019 ΔOwn −1.3%
−$48.3K
547 sh @ $88
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Feb 25, 2019 ΔOwn −1.2%
−$44.7K
506 sh @ $88
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 6, 2018 ΔOwn −12%

Davis J. E. sold $517.3K of DGX, trimming their stake 12%.

−$517.3K
5,122 sh @ $101
DGX
Tax withholding Davis J. E. · EVP, General Diagnostics · Tax withholding · filed Mar 6, 2018 ΔOwn −14%
−$683.2K
6,764 sh @ $101
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 1, 2018 ΔOwn −1.7%

Davis J. E. sold $68K of DGX, trimming their stake 2%.

−$68K
648 sh @ $105

Frequently asked questions

How is Davis J. E.'s win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Davis J. E.'s SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.